On June 5, 2025, PMV Pharmaceuticals held its virtual Annual Meeting where stockholders elected two directors, rejected the executive compensation plan with 20 million votes against, and ratified Ernst & Young as auditors for 2025.
AI Assistant
PMV PHARMACEUTICALS INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.